BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29752719)

  • 21. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.
    Zhang X; Liu S; Hu T; Liu S; He Y; Sun S
    Hepatology; 2009 Aug; 50(2):490-9. PubMed ID: 19472311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A.
    Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z
    Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.
    Luan F; Liu P; Ma H; Yue X; Liu J; Gao L; Liang X; Ma C
    Int J Biochem Cell Biol; 2014 Oct; 55():129-35. PubMed ID: 25195714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma.
    Shi T; Hua Q; Ma Z; Lv Q
    Pathol Res Pract; 2017 Dec; 213(12):1464-1469. PubMed ID: 29103765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.
    Yue X; Zhang Z; Liang X; Gao L; Zhang X; Zhao D; Liu X; Ma H; Guo M; Spear BT; Gong Y; Ma C
    Gastroenterology; 2012 Jun; 142(7):1559-70.e2. PubMed ID: 22406477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes.
    Zhao J; Wang W; Huang Y; Wu J; Chen M; Cui P; Zhang W; Zhang Y
    DNA Cell Biol; 2014 Oct; 33(10):715-22. PubMed ID: 25050974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ-RNF13, as an oncogene, regulates malignant progression of HBV-associated hepatocellular carcinoma cells and HBV infection through ceRNA pathway of circ-RNF13/miR-424-5p/TGIF2.
    Chen Y; Li S; Wei Y; Xu Z; Wu X
    Bosn J Basic Med Sci; 2021 Oct; 21(5):555-568. PubMed ID: 33714261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3'-UTR region of CyclinD1.
    Fu X; Tan D; Hou Z; Hu Z; Liu G
    Int J Mol Sci; 2012; 13(7):8514-8539. PubMed ID: 22942717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.
    Qin X; Li C; Guo T; Chen J; Wang HT; Wang YT; Xiao YS; Li J; Liu P; Liu ZS; Liu QY
    J Exp Clin Cancer Res; 2017 Oct; 36(1):148. PubMed ID: 29052520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
    Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
    Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
    Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
    EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma.
    Liu Y; Feng J; Sun M; Yang G; Yuan H; Wang Y; Bu Y; Zhao M; Zhang S; Zhang X
    Cancer Lett; 2019 Jul; 454():158-170. PubMed ID: 30981758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
    Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.